文献速递神经免疫

针对TRIM9和TRIM67蛋白的高危副肿瘤抗体的检测

Detection of High-Risk Paraneoplastic Antibodies against TRIM9 and TRIM67 Proteins.
PubMed 文献 · Ann Neurol · 2023-09-19

这项回顾性多中心研究评估了疑似TRIM9/67-IgG病例的脑脊液和血清,采用组织免疫荧光、肽噬菌体展示免疫沉淀测序、过表达细胞法检测和免疫印迹,发现细胞法检测最敏感(100%),13例中所有病例均同时具有TRIM9和TRIM67自身抗体,亚急性小脑综合征最常见(7/10),70%合并癌症且多数已转移。

要点

  • 细胞法检测对TRIM9/67-IgG最敏感(100%),所有阳性病例均同时存在TRIM9和TRIM67抗体。
  • 亚急性小脑综合征为最常见表现(7/10),其次为脑炎(3/10)。
  • 10例中70%合并癌症,其中85%为转移性疾病;全部可评估癌活检表达TRIM9蛋白(5/5)。

核心结论

  • TRIM9/67-IgG是一种罕见但可能高危的副肿瘤生物标志物,细胞法检测似乎是最敏感的检测方法。

研究设计与样本

  • 回顾性多中心研究,评估疑似TRIM9/67-IgG病例的脑脊液和血清。
  • 采用组织免疫荧光、肽噬菌体展示免疫沉淀测序、过表达细胞法检测和免疫印迹。
  • 至少2种检测方法检出TRIM9/67-IgG的病例被判定为阳性,共13例。

主要发现

  • 细胞法检测最敏感(100%),所有病例均具有TRIM9和TRIM67自身抗体。
  • 有临床资料的TRIM9/67-IgG病例中,亚急性小脑综合征最常见(7/10),其次为脑炎(3/10)。
  • 10例患者中70%(7/10)合并癌症,其中85%(6/7)为转移性疾病。
  • 全部可评估的癌症活检均表达TRIM9蛋白(5/5),其中4/5例癌组织区域表达升高。

关键数值与推荐

  • 至少2种检测方法检出TRIM9/67-IgG判定为阳性。
  • 细胞法检测敏感度为100%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Co-occurring anti-tripartite motif-containing protein 9 and 67 autoantibodies (TRIM9/67-IgG) have been reported in only a very few cases of paraneoplastic cerebellar syndrome. The value of these biomarkers and the most sensitive methods of TRIM9/67-IgG detection are not known. METHODS: We performed a retrospective, multicenter study to evaluate the cerebrospinal fluid and serum of candidate TRIM9/67-IgG cases by tissue-based immunofluorescence, peptide phage display immunoprecipitation sequencing, overexpression cell-based assay (CBA), and immunoblot. Cases in which TRIM9/67-IgG was detected by at least 2 assays were considered TRIM9/67-IgG positive. RESULTS: Among these cases (n = 13), CBA was the most sensitive (100%) and revealed that all cases had TRIM9 and TRIM67 autoantibodies. Of TRIM9/67-IgG cases with available clinical history, a subacute cerebellar syndrome was the most common presentation (n = 7/10), followed by encephalitis (n = 3/10). Of these 10 patients, 70% had comorbid cancer (7/10), 85% of whom (n = 6/7) had confirmed metastatic disease. All evaluable cancer biopsies expressed TRIM9 protein (n = 5/5), whose expression was elevated in the cancerous regions of the tissue in 4 of 5 cases. INTERPRETATION: TRIM9/67-IgG is a rare but likely high-risk paraneoplastic biomarker for which CBA appears to be the most sensitive diagnostic assay. ANN NEUROL 2023;94:1086-1101.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Bartley CM, Ngo TT, Do LD, et al. Detection of High-Risk Paraneoplastic Antibodies against TRIM9 and TRIM67 Proteins. Ann Neurol. 2023. PMID: 37632288. doi:10.1002/ana.26776

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。